Meade T - Search Results

1

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

Antithrombotic Trialists' (ATT) Collaboration; Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A. Antithrombotic Trialists' (ATT) Collaboration, et al. Among authors: meade t. Lancet. 2009 May 30;373(9678):1849-60. doi: 10.1016/S0140-6736(09)60503-1. Lancet. 2009. PMID: 19482214 Free PMC article.

2

Determination of who may derive most benefit from aspirin in primary prevention: subgroup results from a randomised controlled trial.

Meade TW, Brennan PJ. Meade TW, et al. BMJ. 2000 Jul 1;321(7252):13-7. doi: 10.1136/bmj.321.7252.13. BMJ. 2000. PMID: 10875825 Free PMC article. Clinical Trial.

3

Authors' reply on aspirin for primary prevention.

Meade TW, Brennan PJ. Meade TW, et al. BMJ. 2001 Jan 20;322(7279):171. BMJ. 2001. PMID: 11159585 Free PMC article. No abstract available.

4

Thrombosis prevention trial: compliance with warfarin treatment and investigation of a retained effect.

Rudnicka AR, Ashby D, Brennan P, Meade T. Rudnicka AR, et al. Among authors: meade t. Arch Intern Med. 2003 Jun 23;163(12):1454-60. doi: 10.1001/archinte.163.12.1454. Arch Intern Med. 2003. PMID: 12824095 Clinical Trial.

5

Effects of low intensity antithrombotic regimes on the haemoglobin level.

Meade TW, Howarth DJ, Brennan PJ. Meade TW, et al. Thromb Haemost. 1994 Mar;71(3):284-5. Thromb Haemost. 1994. PMID: 8029790 Clinical Trial.

6

Associations of plasma fibrinogen and factor VII clotting activity with coronary heart disease and stroke: prospective cohort study from the screening phase of the Thrombosis Prevention Trial.

Rudnicka AR, Mt-Isa S, Meade TW. Rudnicka AR, et al. Among authors: meade tw. J Thromb Haemost. 2006 Nov;4(11):2405-10. doi: 10.1111/j.1538-7836.2006.02221.x. Epub 2006 Sep 26. J Thromb Haemost. 2006. PMID: 17002654 Free article. Clinical Trial.

7

Do risk factors change in men at high risk of coronary heart disease? Observations on the effect of health promotion in primary care.

Roderick PJ, Brennan PJ, Meade TW. Roderick PJ, et al. Among authors: meade tw. J Cardiovasc Risk. 1995 Aug;2(4):353-7. J Cardiovasc Risk. 1995. PMID: 8536154 Clinical Trial.

8

Antithrombotic treatment and the incidence of angina pectoris.

Knottenbelt C, Brennan PJ, Meade TW; Medical Research Council's General Practice Research Framework. Knottenbelt C, et al. Arch Intern Med. 2002 Apr 22;162(8):881-6. doi: 10.1001/archinte.162.8.881. Arch Intern Med. 2002. PMID: 11966338 Free article. Clinical Trial.

9

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.

Emerging Risk Factors Collaboration; Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, Danesh J. Emerging Risk Factors Collaboration, et al. Lancet. 2010 Jan 9;375(9709):132-40. doi: 10.1016/S0140-6736(09)61717-7. Epub 2009 Dec 22. Lancet. 2010. PMID: 20031199 Free PMC article.

10

Circulating markers of arterial thrombosis and late-stage age-related macular degeneration: a case-control study.

Rudnicka AR, MacCallum PK, Whitelocke R, Meade TW. Rudnicka AR, et al. Among authors: meade tw. Eye (Lond). 2010 Jul;24(7):1199-206. doi: 10.1038/eye.2010.8. Epub 2010 Feb 12. Eye (Lond). 2010. PMID: 20150922

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

626 results

Search Page